| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Industrial Mechanical > Non-Woven Textile Market - An Introduction |
|
Just Other Articles - Non-Woven Textile Market - An Introduction
Non-wovens are defined as flat structured fabrics, such as sheets or webs, not made by weaving but According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product by bonding and entangling fibers by means of mechanical, thermal or chemical processes.
The major ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in non-woven technologies now available, are needle-punching, thermal-bonding, air laid, spun-bonding, lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. melt blowing and spun lacing/ hydro-entanglement. The non-woven materials produced under these pro here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe esses are extensively used for technical applications such as surgical gowns, diaper cover stocks, d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro utomotive linings, and military applications such as decontamination wipes and geo-textiles such as ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc insulating tank/lake bunds.
India, firmly well-established in commodity textiles such as apparel easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi /made-ups at the rear of its tough cotton economy, has to promote itself into high-value products s nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ch as technical textiles/non-wovens.
Non-woven textiles inside the overall technical textiles is and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ikely to grow globally at an average 8 per cent, with the Asia-Pacific region being expected to sho ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi a vigorous 9.6 per cent annual escalation rate between 2006 and 2009. The world production of non ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a -wovens elevated from 2.16 million tones in 1994 to 4.43 million tones in 2004 with a probable valu dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod jump from $9 billion to $15.9 billion, correspondingly, during this period.
Europe and North Ame cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ica, which had the lion's share of 1.35 million tones and 1.16 million tones, respectively, in 2004 tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen world production figure of 4.43 million tones, may give way to the Asia-Pacific region, which is pr t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel jected to increase its non-woven products productivity from 1.02 million tones in 2004 to 1.67 mill ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ion tones by 2009. At present, the total volume of non-wovens produced from India is estimated at y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products 5,000 tones, as compared to China's non-woven product output of 7.55 lakh tones (China is a dominat . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ng force in non-wovens among the Asia-Pacific region and the third largest non-woven producing regi elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip n after America and Europe because of life-style changes, the rising middle-class, and its economy) tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Gifts with Cash Back on Cash Back Portals How To Become A Full-Time Grantwriter
|